Effect of intranasal salmon calcitonin t
β
K. Overgaard
π
Article
π
1994
π
Springer
π
English
β 578 KB
We examine the dose-related effect of intranasal salmon calcitonin (sCT) on the early postmenopausal bone loss and bone turnover; a 2-year, prospective, randomized, double-blind, placebo-controlled study was carried out with 134 healthy women who had passed a natural menopause within 6 months to 3 y